Baillet F, Brun B, Maylin C, Mazeron J J, Pierquin B, Dreyfus B
J Radiol Electrol Med Nucl. 1977 May;58(5):343-6.
Study 81 cases of Hodgkin's disease at stages I, II or III led to the following conclusions from a therapeutic standpoint (in relation to the apparent results obtained): The addition of chemotherapy on the form of three courses of MOPP before irradiation improved the results of the latter on the one hand and, principally, by reducing the number of failures and, secondly, by reducing the complications. The addition of chemoprophylaxis by MOPP in patients in complete remission as a result of initial treatment, involving an association of 3 courses of MOPP followed by radiotherapy, was not shown to be useful. A major factor in prognosis would to be the clinical and radiological situation after the first three courses of MOPP (in the context of combined MOPP and radiotherapy) since, despite the later radiotherapy, numerous failures were noted in the absence of remission after the three MOPP treatments, whilst failure rarely occurred under the opposite set of circumstances. This is important, since modest treatment would seem to suffice in patients reacting well to three initial MOPP treatments, whilst it is essential to reinforce it when this is not the case.
对81例处于Ⅰ、Ⅱ或Ⅲ期的霍奇金病患者的研究从治疗角度(与所获得的明显结果相关)得出了以下结论:在放疗前增加以三个疗程的MOPP形式的化疗,一方面改善了放疗效果,主要是通过减少失败病例数,其次是通过减少并发症。对于因初始治疗而完全缓解的患者,采用MOPP进行化学预防(包括三个疗程的MOPP联合放疗)未显示出有用性。预后的一个主要因素将是在前三个疗程的MOPP之后(在MOPP与放疗联合的情况下)的临床和放射学状况,因为尽管随后进行了放疗,但在三个MOPP疗程后未缓解的情况下仍观察到大量失败病例,而在相反的情况下很少发生失败。这很重要,因为对于对最初三个MOPP疗程反应良好的患者,适度的治疗似乎就足够了,而在并非如此的情况下加强治疗则至关重要。